Table 2.
Potential predictors of in-hospital mortality and three months' outcome
Comparison of patients survived vs deceased at discharge | Comparison of patients with good vs poor outcomes | |||||
---|---|---|---|---|---|---|
| ||||||
Survived (n=103) | Deceased (n= 28) | p-value | Good outcome (mRS<3) (n= 53) | Poor outcome (mRS≥3) (n= 78) | p-value | |
Age (mean +/− sd), y | 70 +/− 16 | 77 +/− 16 | p = 0.05 * | 70 +/− 16 | 72 +/− 16 | p = 0.45 * |
59% Male | 64% Male | 64% Male | 58% Male | |||
Sex | 41% Female | 36% Female | p = 0.63 ** | 36% Female | 42% Female | p = 0.46 ** |
History of Hypertension | 68/103 (66%) | 22/28 (79%) | p = 0.20 ** | 33/53 (62%) | 57/78 (73%) | p = 0.15 ** |
SBP at admission, mmHg | 165 +/− 38 | 180 +/− 46 | p = 0.09 * | 156+/− 38 | 176+/− 40 | p = 0.01 * |
DBP at admission, mmHg | 84 +/− 23 | 92 +/− 32 | p = 0.13 * | 80 +/− 21 | 90 +/− 28 | p = 0.03 * |
Glucose (mean +/− sd), mg/dL | 145 +/− 56 | 139 +/− 39 | p = 0.59 * | 138 +/− 47 | 147 +/− 57 | p = 0.30 * |
Platelets (mean +/− sd) | 245 +/− 69 | 252 +/− 103 | p = 0.65 * | 238 +/− 68 | 252 +/− 83 | p = 0.30 * |
Anticoagulation | 14/103 (14%) | 8/28 (29%) | p = 0.09 ** | 7/53 (13%) | 15/78 (19%) | p = 0.65 ** |
Antiplatelet Medication | 34/103 (33%) | 12/28 (43%) | p = 0.33 ** | 19/53 (36%) | 27/78 (35%) | p = 0.89 ** |
INR (mean +/− sd) | 1.2 +/− 0.5 | 1.6 +/− 0.8 | p = 0.05 * | 1.2 +/− 0.4 | 1.3 +/− 0.7 | p = 0.11 * |
Vitamin K | 12/103 (12%) | 7/28 (25%) | p = 0.13 + | 5/53 (9%) | 14/78 (18%) | p = 0.21 + |
Platelet transfusion | 8/103 (8%) | 4/28 (14%) | p = 0.28 + | 3/53 (6%) | 9/78 (12%) | p = 0.36 + |
Fresh Frozen Plasma | 11/103 (11%) | 6/28 (21%) | p = 0.20 + | 7/53 (13%) | 10/78 (13%) | p = 1.00 + |
Admission ICH Volume (mean +/− sd), mL | 20.0 +/− 20.7 | 48.6 +/− 39.1 | p = 0.001 * | 15.3 +/− 14.3 | 33.5 +/− 32.6 | p < 0.0001 * |
Follow-up ICH Volume (mean +/− sd), mL | 20.5 +/− 21.1 | 61.6 +/− 48.9 | p < 0.0001 * | 15.1 +/− 14.3 | 38.9 +/− 39.3 | p < 0.0001 * |
Presence of IVH | 29/103 (28%) | 19/28 (68%) | p < 0.0001 ** | 8/53 (15%) | 40/78 (51%) | p < 0.0001 ** |
Time of admission to first CT (mean +/− sd), h | 2.4 +/− 3.0 | 0.9 +/− 0.6 | p<0.0001 * | 2.7 +/− 3.2 | 1.7 +/− 2.4 | P=0.02 * |
Time of first CTto follow up CT (mean +/− sd), h | 14.7 +/− 8.7 | 11.7 +/− 8.6 | p = 0.12 * | 14.1 +/− 7.3 | 14.0 +/− 9.7 | p = 0.97 * |
Admission ICH Volume (median), mL | 12.7 | 38.5 | p < 0.0001 ++ | 9.5 | 18.6 | p < 0.0001 ++ |
Followup ICH volume (median), mL | 13.0 | 64.9 | p < 0.0001 ++ | 10.5 | 18.7 | p < 0.0001 ++ |
Spot sign presence | 12/103 (12%) | 19/28 (68%) | P< 0.0001 ** | 3/53 (6%) | 28/78 (36 %) | P= 0.0002 ** |
SS Score | ||||||
|
||||||
0 | 91 | 9 | P = <.0001 ** | 50 | 50 | P = 0.1483 ** |
|
||||||
1 | 7 | 7 | P = 0.0057 ** | 2 | 12 | P = 0.0347 ** |
|
||||||
2 | 4 | 7 | P = 0.0004 ** | 1 | 10 | P = 0.0269 ** |
|
||||||
3 | 1 | 3 | P = 0.0079 ** | 0 | 4 | P = 0.0943 ** |
|
||||||
4 | 0 | 2 | P = 0.0063 ** | 0 | 2 | P = 0.2401 ** |
|
||||||
Average rate of ICH expansion (mean +/− sd), mL/h | 0.03 +/− 0.39 | 2.81 +/− 5.55 | p = 0.01 * | −0.04 +/− 0.33 | 1.07 +/− 3.55 | p = 0.01 * |
Key:
Student's t-test
Chi- Square Test
Fisher Exact Test
Mann Whitney Test